| 000 | 01295 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516030020.0 | ||
| 264 | 0 | _c20110701 | |
| 008 | 201107s 0 0 ger d | ||
| 022 | _a1439-3522 | ||
| 024 | 7 |
_a10.1055/s-0029-1246093 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScharf, R E | |
| 245 | 0 | 0 |
_a[Hemostatic disorders: clinical management based on molecular mechanisms]. _h[electronic resource] |
| 260 |
_bFortschritte der Neurologie-Psychiatrie _cMar 2011 |
||
| 300 |
_a171-85; quiz 186-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aBlood Platelets _xphysiology |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 |
_aFactor XII _xphysiology |
| 650 | 0 | 4 |
_aFeedback, Physiological _xdrug effects |
| 650 | 0 | 4 | _aFibrinolysis |
| 650 | 0 | 4 |
_aHemorrhagic Disorders _xetiology |
| 650 | 0 | 4 |
_aHemostasis _xgenetics |
| 650 | 0 | 4 |
_aHemostatic Disorders _xetiology |
| 650 | 0 | 4 |
_aHemostatics _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aThrombosis _xetiology |
| 650 | 0 | 4 |
_aVitamin K _xphysiology |
| 773 | 0 |
_tFortschritte der Neurologie-Psychiatrie _gvol. 79 _gno. 3 _gp. 171-85; quiz 186-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0029-1246093 _zAvailable from publisher's website |
| 999 |
_c20666771 _d20666771 |
||